Agenus corporate update and fourth quarter & full year 2021 financial report

Lexington, mass., march 01, 2022 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies and adjuvants designed to activate immune response to cancers and infections, today provided a corporate update and reported financial results for the fourth quarter and full year 2021.
AGEN Ratings Summary
AGEN Quant Ranking